Patents by Inventor John Rambosek

John Rambosek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6174706
    Abstract: DNA encoding triol polyketide synthase (TPKS) has been isolated, purified and sequenced. Expression vectors comprising TPKS, cells transformed with the expression vectors, and processes employing the transformed cells are provided.
    Type: Grant
    Filed: January 8, 1998
    Date of Patent: January 16, 2001
    Assignee: Merck & Co., Inc.
    Inventors: Victor A. Vinci, Michael J. Conder, Phyllis C. McAda, Christopher D. Reeves, John Rambosek, Charles Ray Davis, Lee E. Hendrickson
  • Patent number: 6071713
    Abstract: A bioprocess for preparing adipoyl-7-ACA comprising the steps: (a) transforming cells of a strain of Penicillium chrysogenum which produces isopenicillin N with an expression vector containing DNA encoding an enzyme, having expandase activity capable of accepting adipoyl 6-APA as a substrate, an enzyme having hydroxylase activity capable of accepting adipoyl-7-ADCA as a substrate and an enzyme having acetyl transferase activity capable of accepting adipoyl 7-ADAC as a substrate; (b) culturing the transformed cells from step a) in a suitable culture medium containing an adipate feedstock, wherein said cells produce adipoyl 6-APA; and (c) culturing the transformed cells producing adipoyl 6-APA of step b) under conditions suitable for expression of said DNA encoding enzyme, thereby producing the end product adipoyl-7-ACA.
    Type: Grant
    Filed: June 28, 1999
    Date of Patent: June 6, 2000
    Assignee: Gist-Brocades B.V.
    Inventors: Michael J. Conder, John A. Rambosek, Phyllis C. McAda, Christopher D. Reeves
  • Patent number: 6017726
    Abstract: A process for making 7-aminodeacetyl-cephalosporanic acid (7-ADAC).
    Type: Grant
    Filed: April 17, 1997
    Date of Patent: January 25, 2000
    Assignee: Gist-Brocades B.V.
    Inventors: Michael J. Conder, John A. Rambosek, Phyllis C. McAda, Christopher D. Reeves
  • Patent number: 5879914
    Abstract: This invention relates to recombinant DNA molecule containing a gene or genes which encode a biocatalyst capable of desulfurizing a fossil fuel which contains organic sulfur molecules. For example, the present invention encompasses a recombinant DNA molecule containing a gene or genes of a strain of Rhodococcus rhodochrous.
    Type: Grant
    Filed: April 14, 1995
    Date of Patent: March 9, 1999
    Assignee: Energy BioSystems Corporation
    Inventors: John Rambosek, Chris S. Piddington, Brian R. Kovacevich, Kevin D. Young, Sylvia A. Denome
  • Patent number: 5849541
    Abstract: DNA encoding triol polyketide synthase (TPKS) from Aspergillus terreus has been isolated, purified and sequenced. Expression vectors comprising said DNA, cells transformed with the expression vectors, and processes employing the transformed cells are provided.
    Type: Grant
    Filed: August 23, 1996
    Date of Patent: December 15, 1998
    Assignee: Merck & Co., Inc.
    Inventors: Victor A. Vinci, Michael J. Conder, Phyllis C. McAda, Christopher D. Reeves, John Rambosek, Charles Ray Davis, Lee E. Hendrickson
  • Patent number: 5834286
    Abstract: The present invention provides a recombinant combination strain which is capable of over-expressing at least two different genes under two separate promoters in filamentous fungi. The genes encode phytase and pH 2.5 acid phosphatase. Mixtures containing desired ratios of the two enzymes are prepared by recombinant DNA techniques. The enzyme mixtures show a cooperative effect in the degradation of phytic acid and its salts. The preferred ratios of the two enzymes are from about 3:1 to about 16:1.
    Type: Grant
    Filed: May 24, 1995
    Date of Patent: November 10, 1998
    Assignee: Rohm Enzyme Finland Oy
    Inventors: Helena K. M. Nevalainen, Marja T. Paloheimo, Richard B. Fagerstrom, Arja S. K. Miettinen-Oinonen, Marja K. Turunen, John A. Rambosek, Christopher S. Piddington, Christine S. Houston, Michael A. Cantrell
  • Patent number: 5830733
    Abstract: The present invention provides a nucleic acid molecule encoding a phytase. The present invention also provides a nucleic acid molecule encoding a pH 2.5 acid phosphatase. Also provided are vectors, host cells, and a method of overexpressing phytate degrading enzymes.
    Type: Grant
    Filed: March 1, 1996
    Date of Patent: November 3, 1998
    Assignee: Rohm Enzyme Finland Oy
    Inventors: Helena K. M. Nevalainen, Marja T. Paloheimo, Arja S. K. Miettinen-Oinonen, Tuula K. Torkkeli, Michael Cantrell, Christopher S. Piddington, John A. Rambosek, Marja K. Turunen, Richard B. Fagerstrom, Christine S. Houston
  • Patent number: 5780292
    Abstract: A highly efficient overexpression system for phytase and pH 2.5 acid phosphatase in Trichoderma is described. This system results in enzyme compositions that are especially useful in the animal feed industry.
    Type: Grant
    Filed: July 31, 1992
    Date of Patent: July 14, 1998
    Assignee: Alko Group Ltd.
    Inventors: Helena K. M. Nevalainen, Marja T. Paloheimo, Aria S. K. Miettinen-Oinonen, Tuula K. Torkkeli, Michael Cantrell, Cristopher S. Piddington, John A. Rambosek, Marja K. Turunen, Richard B. Fagerstrom
  • Patent number: 5744350
    Abstract: DNA encoding triol polyketide synthase (TPKS) has been isolated, purified and sequenced. Expression vectors comprising TPKS, cells transformed with the expression vectors, and processes employing the transformed cells are provided.
    Type: Grant
    Filed: May 25, 1995
    Date of Patent: April 28, 1998
    Assignee: Merck & Co., Inc.
    Inventors: Victor A. Vinci, Michael J. Conder, Phyllis C. McAda, Christopher D. Reeves, John Rambosek, Charles Ray Davis, Lee E. Hendrickson
  • Patent number: 5629171
    Abstract: Important intermediates for preparing cephalosporin antibiotics, 7-amino-cephalosporanic acid (7-ACA) and 7-aminodeacetylcephalosporanic acid (7-ADAC), are prepared by a novel bioprocess in which a transformed Penicillium chrysogenum strain is cultured in the presence of an adipate feedstock to produce adipoyl-6-APA (6-amino penicillanic acid); followed by the in situ expression of the following genes with which the P. chrysogenum has been transformed:1) an expandase gene, whose expression product converts the adipoyl-6-APA by ring expansion to adipoyl-7-ADCA;2) an hydroxylase gene whose expression product converts the 3-methyl side chain of adipoyl-7-ADCA to 3-hydroxymethyl, to give the first product, 7-aminodeacetylcephalosporanic acid (7-ADAC); and3) an acetyltransferase gene whose expression product converts the 3-hydroxymethyl side chain to the 3-acetyloxymethyl side chain of 7-ACA. The final product, 7-ACA, is then prepared by cleavage of the adipoyl side chain using an adipoyl acylase.
    Type: Grant
    Filed: May 11, 1995
    Date of Patent: May 13, 1997
    Assignee: Gist-Brocades B.V.
    Inventors: Michael J. Conder, John A. Rambosek, Phyllis C. McAda, Christopher D. Reeves
  • Patent number: 5578478
    Abstract: This invention relates to a recombinant DNA molecule containing a gene or genes which encode a biocatalyst capable of desulfurizing a fossil fuel which contains organic sulfur molecules. For example, the present invention encompasses a recombinant DNA molecule containing a gene or genes of a strain of Rhodococcus rhodochrous.
    Type: Grant
    Filed: April 14, 1995
    Date of Patent: November 26, 1996
    Assignee: Energy BioSystems Corporation
    Inventors: John Rambosek, Chris S. Piddington, Brian R. Kovacevich, Kevin D. Young, Sylvia A. Denome
  • Patent number: 5559005
    Abstract: Important intermediates for preparing cephalosporin antibiotics, 7-amino-cephalosporanic acid (7-ACA) and 7-aminodeacetylcephalosporanic acid (7-ADAC), are prepared by a novel bioprocess in which a transformed Penicillium chrysogenum strain is cultured in the presence of an adipate feedstock to produce adipoyl-6-APA (6-amino penicillanic acid); followed by the in situ expression of the following genes with which the P. chrysogenum has been transformed:1) an expandase gene, e.g., from Cephalosporium acremonium, whose expression product converts the adipoyl-6-APA by ring expansion to adipoyl-7-ADCA;2) an hydroxylase gene whose expression product converts the 3-methyl side chain of adipoyl-7-ADCA to 3-hydroxymethyl, to give the first product, 7-aminodeacetylcephalosporanic acid (7-ADAC); and3) an acetyltransferase gene whose expression product converts the 3-hydroxymethyl side chain to the 3-acetyloxymethyl side chain of 7-ACA.
    Type: Grant
    Filed: May 27, 1994
    Date of Patent: September 24, 1996
    Assignee: Merck & Co., Inc.
    Inventors: Michael J. Conder, Phyllis C. McAda, John A. Rambosek, Christopher D. Reeves
  • Patent number: 5356801
    Abstract: This invention relates to a recombinant DNA molecule containing a gene or genes which encode a biocatalyst capable of desulfurizing a fossil fuel which contains organic sulfur molecules. For example, the present invention encompasses a recombinant DNA molecule containing a gene or genes of a strain of Rhodococcus rhodochrous.
    Type: Grant
    Filed: July 9, 1993
    Date of Patent: October 18, 1994
    Assignee: Energy BioSystems Corporation
    Inventors: John Rambosek, Chris S. Piddington, Brian R. Kovacevich, Kevin D. Young, Sylvia A. Denome
  • Patent number: 5318896
    Abstract: An important intermediate for preparing cephalosporin antibiotics, 7-aminodesacetoxy cephalosporanic acid (7-ADCA), is prepared by a novel bioprocess in which a transformed Penicillium chrysogenum strain is cultured in the presence of an adipate feedstock to produce adipoyl-6-APA (6-amino penicillanic acid); and the in situ expression of an expandase gene, e.g., from Streptomyces clavuligerus, with which the P. chrysogenum has been transformed, converts the adipoly-6-APA by ring expansion to adipoyl-7-ADCA. The final product, 7-ADCA, is then prepared by cleavage of the adipoyl side chain using an adipoyl acylase. The entire synthesis, accordingly, is carried out using bioprocesses, and is efficient and economical.
    Type: Grant
    Filed: August 28, 1992
    Date of Patent: June 7, 1994
    Assignee: Merck & Co., Inc.
    Inventors: Michael J. Conder, Phyllis C. McAda, John A. Rambosek
  • Patent number: 5229274
    Abstract: A process for the one-step conversion of cephalosporin C and derivatives thereof to the corresponding 7-aminocephalosporanic acid and derivatives comprising treating said cephalosporin C and derivatives with a cephalosporin C amidase enzyme of a recited sequence, the DNA encoding said enzyme, and expression thereof in a suitable host, e.g., Bacillus species under the control of a suitable promoter.
    Type: Grant
    Filed: January 13, 1992
    Date of Patent: July 20, 1993
    Assignee: Merck & Co., Inc.
    Inventors: Mark S. Crawford, David B. Finkelstein, John A. Rambosek
  • Patent number: 5104800
    Abstract: A process for the one-step conversion of cephalosporin C and derivatives thereof to the corresponding 7-aminocephalosporanic acid and derivatives comprising treating said cephalosporin C and derivatives with a cephalosporin C amidase enzyme of a recited sequence, the DNA encoding said enzyme, and expression thereof in a suitable host, e.g., Bacillus species under the control of a suitable promoter.
    Type: Grant
    Filed: June 27, 1989
    Date of Patent: April 14, 1992
    Assignee: Merck & Co., Inc.
    Inventors: Mark S. Crawford, David B. Finkelstein, John A. Rambosek